ApplevsHealth Catalyst

AAPL and HCAT stock compared: price, dividend, valuation and results, from SEC filings.

HCAT

Health Catalyst, Inc

$1.38

Value $102M

-8.61%
HCAT's page

Apple (AAPL) has a market value of $5.13T and Health Catalyst (HCAT) $102M. Over the last year, with dividends, AAPL moved +30.0% and HCAT -39.2%. Dividend yield: AAPL 0.30%, HCAT none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AAPL$5.13T

    HCAT$102M

    AAPL is 50,485 times HCAT

  • Revenue, 12 months

    AAPL$479B

    HCAT$272M

    AAPL is 1,759 times HCAT

  • Net income, 12 months

    AAPL$132B

    HCAT-$202M

  • Operating margin

    AAPL33.0%

    HCAT-65.7%

    98.7 points apart

  • ROIC

    AAPL72.1%

    HCAT-44.9%

    116.9 points apart

  • P/E

    AAPL38.8

    HCAT–

  • Dividend yield

    AAPL0.3%

    HCAT0.0%

    0.3 points apart

  • 5-year return

    AAPL+140.9%

    HCAT-97.2%

    238.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AAPL+140.9%

HCAT-97.2%

010020020222023202420252026
Returns by period
PeriodAAPLWith dividendsHCATWith dividends
1 year since November 14, 2025+30.0%Price +29.5%-39.2%Price -39.2%
3 years since November 16, 2023+88.4%+23.5% a yearPrice +86.0%-82.4%-44.0% a yearPrice -82.4%
5 years since November 15, 2021+140.9%+19.2% a yearPrice +135.2%-97.2%-51.1% a yearPrice -97.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AAPLAppleHCATHealth Catalyst

Valuation

AAPLHCAT
Valuation
Price$352.78$1.38
Market value$5.13T$102M
Enterprise value (EV)$5.15T$23M
P/E38.8–
P/E, 5-year median34.2–
P/B45.70.7
EV/EBIT32.6–
Free cash flow yield2.7%25.3%

Results and growth

AAPLHCAT
Results and growth
Revenue, 12 months$479B$272M
Net income, 12 months$132B-$202M
Free cash flow, 12 months$136B$26M
Earnings per share, 12 months$8.98-$2.85
Revenue growth, year on year15.1%1.5%
Revenue growth a year, past+5.5%over 5 years+10.5%over 5 years
EPS growth a year, past+9.9%over 5 years–

Margins and returns on capital

AAPLHCAT
Margins and returns on capital
Gross margin48.8%49.1%
Operating margin33.0%-65.7%
Net margin27.6%-74.2%
ROIC72.1%-44.9%
ROE135.4%-105.0%

Balance sheet

AAPLHCAT
Balance sheet
Cash$56.7B$79M
Total debt$94.5B$16M
Net debt / EBITDA0.1–
Interest cover––

Dividends and buybacks

AAPLHCAT
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$1.07–
Dividend growth a year, past+4.5%over 5 years–
Buyback yield1.7%4.9%
Shareholder yield2.0%4.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AAPL or HCAT

Didn't find what you were looking for?

Ask us
Which is bigger, Apple or Health Catalyst?

By market value, Apple ($5.13T) is about 50,484.7 times Health Catalyst ($102M), at today's prices.

How did AAPL and HCAT stock do over the last 5 years?

Since November 15, 2021, AAPL's price moved +135.2% and HCAT's -97.2%. With dividends: AAPL +140.9% (+19.2% a year), HCAT -97.2% (-51.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AAPL or HCAT?

The dividend yield at today's price is 0.30% for Apple and none for Health Catalyst. Over the last twelve months they paid $1.07 and – per share.

Which has the higher profit margins, Apple or Health Catalyst?

Over the last twelve months, the net margin was 27.6% for Apple and -74.2% for Health Catalyst, and the operating margin 33.0% and -65.7%. Revenue was $479B and $272M.

Which is the better investment, Apple or Health Catalyst?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.